| ￥5800 在线订购包邮(港澳台除外) | |
| Z04020-100 | |
|
|
|
|
|
|
|
|
|
| 咨询产品问题 | |
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Conjugate | Biotin | ||||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 67.1 kDa | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS，(pH 7.4). | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized Anti-CD5 Antibody, hFc Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for CD5 hFc Chimera[Biotin], Avi, Human, hFc Tag with the EC50 of 12.4 ng/ml determined by ELISA. »
The purity of CD5 hFc Chimera[Biotin], Avi, Human is greater than 95% as determined by SEC-HPLC. »
CD5 hFc Chimera[Biotin], Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | CD5: a type I transmembrane protein found on T cells, thymocytes, and some B cells that is a ligand for CD72 and is involved in cellular activation or adhesion; expressed in B-cell chronic lymphocytic leukemia and T-cell lymphoma. |
| Synonyms | CD5 molecule; CD5; LEU1; T1; CD5 antigen |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
